Humira, Enbrel Face Pricing Pressures From Copay Accumulator Programs
Executive Summary
Payer efforts to undercut copay assistance are getting manufacturers’ attention. PhRMA launches ad campaign warning patients that 'middlemen' are 'trying to keep you from reaching your deductible.'